Free Trial

Vapotherm Q3 2023 Earnings Report

Vapotherm EPS Results

Actual EPS
-$2.26
Consensus EPS
-$2.20
Beat/Miss
Missed by -$0.06
One Year Ago EPS
N/A

Vapotherm Revenue Results

Actual Revenue
$15.17 million
Expected Revenue
$16.29 million
Beat/Miss
Missed by -$1.12 million
YoY Revenue Growth
N/A

Vapotherm Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

Just head over here!

Vapotherm Earnings Headlines

Vapotherm, Inc.: Vapotherm Announces Closing of Merger
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Vapotherm Announces Closing of Merger
See More Vapotherm Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vapotherm? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vapotherm and other key companies, straight to your email.

About Vapotherm

Vapotherm (NYSE:VAPO), a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

View Vapotherm Profile

More Earnings Resources from MarketBeat

Upcoming Earnings